The weekly litigation news digest is live. Subscribe now

IP Verse

Trans-Resveratrol Or Trans-Resveratrol Derivative Composition - EP2934698

The patent EP2934698 was granted to L'Oreal on Jan 30, 2019. The application was filed on Dec 20, 2013 under application number EP13826885A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2934698

L'OREAL
Application Number
EP13826885A
Filing Date
Dec 20, 2013
Status
Opposition Rejected
Dec 25, 2020
Publication Date
Jan 30, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
IPAZOct 22, 2019IPAZADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0669323
DESCRIPTIONUS2463264
DESCRIPTIONUS6225467
DESCRIPTIONWO2004085412
DESCRIPTIONWO2006034982
DESCRIPTIONWO2006034985
DESCRIPTIONWO2006034991
DESCRIPTIONWO2006034992
DESCRIPTIONWO2006035000
DESCRIPTIONWO2006035007
DESCRIPTIONWO9206778
INTERNATIONAL-SEARCH-REPORTUS2012213845
INTERNATIONAL-SEARCH-REPORTWO2012069362
INTERNATIONAL-SEARCH-REPORTWO2012069363
OPPOSITIONFR2939669
OPPOSITIONUS2011251242
OPPOSITIONUS2463264
OPPOSITIONUS5585091
OPPOSITIONWO2012069363

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents